LAURUS LABS LIMITED (LAURUSLABS) financials

LAURUS LABS LIMITED (LAURUSLABS) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Market Cap: ₹1,11,310Cr.
Current Price: ₹2,060
Stock P/E: 128
ROE: 15.2%
ROCE: 16.0%
Book Value: ₹97.3
Dividend Yield: 0.10%
52W High / Low: ₹2,086/901

In Jun 2026, LAURUS LABS LIMITED (LAURUSLABS) reported sales ₹1,757 Cr and net profit ₹290 Cr.

Annual TTM: sales ₹6,413 Cr, net profit ₹872 Cr.

Shareholding: Promoters 27.47% (Jun 2026), FIIs 28.00% (Jun 2026), DIIs 13.73% (Jun 2026), Public 30.79% (Jun 2026), No. of Shareholders 2,91,653% (Jun 2026).

LAURUSLABS quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	1,185	1,265	1,650	1,433	1,567	1,509	1,580	1,757
Expenses	1,003	1,059	1,255	1,105	1,177	1,164	1,205	1,258
Operating Profit	182	206	395	327	390	346	375	499
OPM %	15%	16%	24%	23%	25%	23%	24%	28%
Other Income	12	7	72	22	28	14	13	20
Interest	45	48	49	44	34	31	34	35
Depreciation	91	89	88	94	96	94	95	96
Profit before tax	58	77	330	211	289	234	259	388
Tax %	27%	25%	24%	25%	25%	25%	26%	25%
Net Profit	42	57	252	158	216	175	192	290
EPS in Rs	0.79	1.06	4.67	2.93	4.00	3.24	3.55	5.37
Raw PDF	—	—	—	—	—	—	—	—

LAURUSLABS profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	2,797	4,769	4,707	5,773	4,812	5,217	6,089	6,413
Expenses	2,226	3,258	3,421	4,292	4,062	4,273	4,646	4,804
Operating Profit	571	1,511	1,286	1,482	751	944	1,443	1,610
OPM %	20%	32%	27%	26%	16%	18%	24%	25%
Other Income	5	26	20	16	47	100	73	76
Interest	88	66	96	146	151	182	143	134
Depreciation	184	197	235	301	345	359	379	381
Profit before tax	304	1,275	975	1,051	301	504	994	1,171
Tax %	12%	25%	23%	28%	26%	24%	26%	—
Net Profit	267	956	750	760	224	380	740	872
EPS in Rs	5.00	17.82	13.96	14.12	4.15	7.05	13.72	16.16
Dividend Payout %	10%	11%	14%	14%	19%	17%	15%	—

LAURUSLABS balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	106	107	107	107	108	108	108	108
Reserves	1,484	1,709	2,605	3,281	3,949	4,099	4,456	5,144
Borrowings	1,009	1,051	1,411	1,653	1,714	2,110	2,380	2,080
Other Liabilities	718	872	1,502	1,567	1,187	1,351	1,643	2,208
Total Liabilities	3,318	3,739	5,625	6,609	6,958	7,667	8,587	9,540
Fixed Assets	1,599	1,694	1,818	2,186	2,884	3,036	2,888	3,041
CWIP	107	67	324	755	357	156	336	569
Investments	58	58	319	362	384	635	740	891
Other Assets	1,554	1,920	3,164	3,306	3,333	3,841	4,623	5,039
Total Assets	3,318	3,739	5,625	6,609	6,958	7,667	8,587	9,540

LAURUSLABS cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	293	345	694	823	882	659	540	1,385
Cash from Investing Activity	-257	-217	-900	-837	-735	-757	-592	-847
Cash from Financing Activity	-37	-127	243	15	-185	139	59	-551
Net Cash Flow	-0	0	38	2	-39	41	8	-13
Free Cash Flow	42	127	98	62	141	293	258	677
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	90%	67%	61%	77%	78%	101%	71%	116%

LAURUSLABS shareholding pattern (%)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoters	27.18%	27.62%	27.62%	27.60%	27.60%	27.49%	27.49%	27.47%
FIIs	26.08%	25.56%	25.51%	25.70%	26.17%	26.52%	25.82%	28.00%
DIIs	13.05%	12.74%	11.78%	11.94%	11.72%	12.42%	13.96%	13.73%
Public	33.69%	34.09%	35.09%	34.78%	34.52%	33.57%	32.73%	30.79%
No. of Shareholders	3,09,063	2,92,214	2,92,905	2,80,223	2,83,678	2,80,756	2,92,281	2,91,653

LAURUSLABS key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	112	102	98	98	94	124	142	121
Inventory Days	201	233	257	279	211	258	258	304
Days Payable	144	157	194	140	90	151	138	171
Cash Conversion Cycle	169	177	161	237	216	231	262	255
Working Capital Days	9	19	50	57	67	56	56	64
ROCE %	8%	14%	38%	23%	22%	8%	9%	16%

LAURUSLABSUpdated 18 Oct 2026, 5:02

Laurus Labs Limited

LAURUSLABSUpdated 18 Oct 2026, 5:02

Market Cap

₹1,11,310Cr.

Current Price

₹2,060

High / Low

₹2,086/901

Stock P/E

128

ROE15.2%

ROCE16.0%

Book Value₹97.3

Face Value₹2.00

Dividend Yield0.10%

About

Founded in 2005, Laurus Labs is a research-driven pharmaceutical and biotechnology company having a global leadershipposition in select Active Pharmaceutical Ingredients (APIs) including anti-retroviral, oncology drugs (including High Potent APIs), Cardiovascular, and Gastro therapeutics. They also offer integrated CMO and CDMO services to Global Innovators from Clinical phase drug development to commercial manufacturing.Laurus employs 6,500+ people, including around 1,050+ scientists, at more than 11 facilities approved by global agencies USFDA, WHO-Geneva, Japan-PDMA, UK-MHRA, EMA, TGA etc.[1]

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	1108	33	980	7	84	17	24	13	0.24
Sep 2023	1158	38	978	6	85	63	26	47	0.87
Dec 2023	1132	38	962	11	87	57	25	43	0.79
Mar 2024	1415	42	1143	24	89	164	26	121	2.25
Jun 2024	1117	41	956	9	91	39	26	29	0.53
Sep 2024	1185	45	1003	12	91	58	27	42	0.79
Dec 2024	1265	48	1059	7	89	77	25	57	1.06
Mar 2025	1650	49	1255	72	88	330	24	252	4.67
Jun 2025	1433	44	1105	22	94	211	25	158	2.93
Sep 2025	1567	34	1177	28	96	289	25	216	4
Dec 2025	1509	31	1164	14	94	234	25	175	3.24
Mar 2026	1580	34	1205	13	95	259	26	192	3.55
Jun 2026	1757	35	1258	20	96	388	25	290	5.37

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	1326	106	1121	34	61	72	-2	74	2.37
Mar 2016	1775	111	1402	4	86	180	19	145	4.59
Mar 2017	1892	97	1478	32	104	245	18	200	3.78
Mar 2018	2027	75	1618	28	121	241	28	173	3.27
Mar 2019	2236	86	1884	15	161	121	22	95	1.78
Mar 2020	2797	88	2226	5	184	304	12	267	5
Mar 2021	4769	66	3258	26	197	1275	25	956	17.82
Mar 2022	4707	96	3421	20	235	975	23	750	13.96
Mar 2023	5773	146	4292	16	301	1051	28	760	14.12
Mar 2024	4812	151	4062	47	345	301	26	224	4.15
Mar 2025	5217	182	4273	100	359	504	24	380	7.05
Mar 2026	6089	143	4646	73	379	994	26	740	13.72
TTM	6413	134	4804	76	381	1171	—	872	16.16

Shareholding pattern

As of Jun 2026%

Holder	Share
Promoters	27.47%
FIIs	28%
DIIs	13.73%
Public	30.79%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public
Sep 2023	27.2%	24.03%	11.01%	37.75%
Dec 2023	27.18%	25.39%	11.13%	36.3%
Mar 2024	27.18%	25.98%	11.78%	35.07%
Jun 2024	27.18%	25.67%	13.56%	33.59%
Sep 2024	27.18%	26.08%	13.05%	33.69%
Dec 2024	27.62%	25.56%	12.74%	34.09%
Mar 2025	27.62%	25.51%	11.78%	35.09%
Jun 2025	27.6%	25.7%	11.94%	34.78%
Sep 2025	27.6%	26.17%	11.72%	34.52%
Dec 2025	27.49%	26.52%	12.42%	33.57%
Mar 2026	27.49%	25.82%	13.96%	32.73%
Jun 2026	27.47%	28%	13.73%	30.79%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2015	16	645	888	344	1893	801	107	19	966	1893
Mar 2016	16	790	1081	342	2229	1014	70	26	1119	2229
Mar 2017	106	1250	808	509	2673	1193	143	51	1286	2673
Mar 2018	106	1407	947	547	3008	1448	163	52	1345	3008
Mar 2019	106	1484	1009	718	3318	1599	107	58	1554	3318
Mar 2020	107	1709	1051	872	3739	1694	67	58	1920	3739
Mar 2021	107	2605	1411	1502	5625	1818	324	319	3164	5625
Mar 2022	107	3281	1653	1567	6609	2186	755	362	3306	6609
Mar 2023	108	3949	1714	1187	6958	2884	357	384	3333	6958
Mar 2024	108	4099	2110	1351	7667	3036	156	635	3841	7667
Mar 2025	108	4456	2380	1643	8587	2888	336	740	4623	8587
Mar 2026	108	5144	2080	2208	9540	3041	569	891	5039	9540

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	-59	-406	486	21
Mar 2016	197	-315	90	-27
Mar 2017	321	-282	-47	-8
Mar 2018	369	-417	49	0
Mar 2019	293	-257	-37	0
Mar 2020	345	-217	-127	0
Mar 2021	694	-900	243	38
Mar 2022	823	-837	15	2
Mar 2023	882	-735	-185	-39
Mar 2024	659	-757	139	41
Mar 2025	540	-592	59	8
Mar 2026	1385	-847	-551	-13

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	78	91	108	100	112	102	98	98	94	124	142	121
Inventory Days	210	177	184	199	201	233	257	279	211	258	258	304
Days Payable	101	91	110	106	144	157	194	140	90	151	138	171
Cash Conversion Cycle	187	177	183	193	169	177	161	237	216	231	262	255
Working Capital Days	-0	20	7	-7	9	19	50	57	67	56	56	64
ROCE %	15%	17%	17%	14%	8%	14%	38%	23%	22%	8%	9%	16%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of LAURUS LABS LIMITED (LAURUSLABS)?

The reported market capitalisation for LAURUS LABS LIMITED (LAURUSLABS) is ₹1,11,310Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of LAURUSLABS?

The current price shown for LAURUS LABS LIMITED (LAURUSLABS) on Fincrux is ₹2,060 with a 52-week high/low of ₹2,086/901.

What is the P/E ratio of LAURUS LABS LIMITED (LAURUSLABS)?

The stock P/E for LAURUS LABS LIMITED (LAURUSLABS) is 128 on Fincrux, with ROE at 15.2% and ROCE at 16.0%.

What were LAURUSLABS latest quarterly results?

For Jun 2026, LAURUS LABS LIMITED (LAURUSLABS) reported sales ₹1,757 Cr and net profit ₹290 Cr (figures in ₹ crore unless noted).

What are LAURUSLABS annual sales and net profit?

For TTM, LAURUS LABS LIMITED (LAURUSLABS) shows sales of ₹6,413 Cr and net profit of ₹872 Cr on the Fincrux profit & loss statement.

Who owns LAURUS LABS LIMITED (LAURUSLABS)?

Latest shareholding for LAURUS LABS LIMITED (LAURUSLABS) on Fincrux: Promoters 27.47% (Jun 2026), FIIs 28.00% (Jun 2026), DIIs 13.73% (Jun 2026), Public 30.79% (Jun 2026), No. of Shareholders 2,91,653% (Jun 2026).

Where can I find LAURUS LABS LIMITED (LAURUSLABS) financials?

LAURUS LABS LIMITED (LAURUSLABS) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show LAURUSLABS balance sheet and cash flow?

Yes. The LAURUS LABS LIMITED (LAURUSLABS) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 18 October 2026 at 5:02